V

VistaGen Therapeutics Inc
NASDAQ:VTGN

Watchlist Manager
VistaGen Therapeutics Inc
NASDAQ:VTGN
Watchlist
Price: 2.93 USD -2.98% Market Closed
Market Cap: 79.3m USD
Have any thoughts about
VistaGen Therapeutics Inc?
Write Note

Wall Street
Price Targets

VTGN Price Targets Summary
VistaGen Therapeutics Inc

Wall Street analysts forecast VTGN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for VTGN is 13.26 USD with a low forecast of 12.12 USD and a high forecast of 15.75 USD.

Lowest
Price Target
12.12 USD
314% Upside
Average
Price Target
13.26 USD
353% Upside
Highest
Price Target
15.75 USD
438% Upside
VistaGen Therapeutics Inc Competitors:
Price Targets
MCRB
Seres Therapeutics Inc
498% Upside
SPRY
ARS Pharmaceuticals Inc
58% Upside
AUTL
Autolus Therapeutics PLC
219% Upside
CYTK
Cytokinetics Inc
50% Upside
MIRM
Mirum Pharmaceuticals Inc
48% Upside
EXAS
Exact Sciences Corp
62% Upside
ANIK
Anika Therapeutics Inc
108% Upside
ELDN
Eledon Pharmaceuticals Inc
196% Upside

Revenue
Forecast

Revenue Estimate
VistaGen Therapeutics Inc

The compound annual growth rate of VistaGen Therapeutics Inc's revenue for the next 3 years is 89%.

N/A
Past Growth
89%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
VistaGen Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
VistaGen Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is VTGN's stock price target?
Price Target
13.26 USD

According to Wall Street analysts, the average 1-year price target for VTGN is 13.26 USD with a low forecast of 12.12 USD and a high forecast of 15.75 USD.

What is VistaGen Therapeutics Inc's Revenue forecast?
Projected CAGR
89%

The compound annual growth rate of VistaGen Therapeutics Inc's revenue for the next 3 years is 89%.

Back to Top